Bomedemstat is a small-molecule LSD1 inhibitor (IMG-7289) that has been tested in various hematopoietic cancers, including essential thrombocythemia (ET), AML, MF, and PV [68]. The gene discussed is KDM1A; the disease is essential thrombocythemia.